Lantern Research Development from 2010 to 2026
| LTRN Stock | USD 3.15 0.04 1.29% |
Research Development | First Reported 2019-03-31 | Previous Quarter 3.1 M | Current Value 2.4 M | Quarterly Volatility 1.4 M |
Check Lantern Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lantern Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.2 K, Interest Expense of 246.8 K or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.53. Lantern financial statements analysis is a perfect complement when working with Lantern Pharma Valuation or Volatility modules.
Lantern | Research Development | Build AI portfolio with Lantern Stock |
Evaluating Lantern Pharma's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Lantern Pharma's fundamental strength.
Latest Lantern Pharma's Research Development Growth Pattern
Below is the plot of the Research Development of Lantern Pharma over the last few years. It is Lantern Pharma's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lantern Pharma's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Lantern Research Development Regression Statistics
| Arithmetic Mean | 5,326,772 | |
| Geometric Mean | 1,916,207 | |
| Coefficient Of Variation | 131.28 | |
| Mean Deviation | 5,911,673 | |
| Median | 572,095 | |
| Standard Deviation | 6,992,884 | |
| Sample Variance | 48.9T | |
| Range | 18.9M | |
| R-Value | 0.86 | |
| Mean Square Error | 13.9T | |
| R-Squared | 0.73 | |
| Significance | 0.000012 | |
| Slope | 1,185,734 | |
| Total Sum of Squares | 782.4T |
Lantern Research Development History
About Lantern Pharma Financial Statements
Lantern Pharma investors utilize fundamental indicators, such as Research Development, to predict how Lantern Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 18.5 M | 19.5 M |
Pair Trading with Lantern Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lantern Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Lantern Stock
Moving against Lantern Stock
The ability to find closely correlated positions to Lantern Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lantern Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lantern Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lantern Pharma to buy it.
The correlation of Lantern Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lantern Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lantern Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lantern Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Lantern Pharma Correlation against competitors. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could Lantern diversify its offerings? Factors like these will boost the valuation of Lantern Pharma. Expected growth trajectory for Lantern significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lantern Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Lantern Pharma requires distinguishing between market price and book value, where the latter reflects Lantern's accounting equity. The concept of intrinsic value—what Lantern Pharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Lantern Pharma's price substantially above or below its fundamental value.
Understanding that Lantern Pharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lantern Pharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lantern Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.